BK-EBDP

Introduction

BK-EBDP, also known as β-Keto-3,4-methylenedioxy-α-propyl-N-ethyl-phenethylamine, is a synthetic stimulant drug that belongs to the cathinone class. It is structurally similar to other cathinone compounds such as methylone and ethylene. BK-EBDP is a white crystalline powder that can be orally ingested, insufflated, or injected. It has gained popularity as a designer drug and is often sold online as a research chemical.

Chemical Properties

BK-EBDP has a molecular weight of 249.31 g/mol and a molecular formula of C14H19NO3. It is a chiral compound with two enantiomers, (R)-BK-EBDP and (S)-BK-EBDP. The melting point of BK-EBDP is approximately 122-124 °C. The compound has a solubility of 33.2 mg/mL in water at 25 °C.

Pharmacology

BK-EBDP acts as a dopamine and norepinephrine reuptake inhibitor, which means it increases the levels of these neurotransmitters in the brain. This leads to a feeling of euphoria, increased energy, and increased sociability. BK-EBDP also acts as a serotonin releaser, which can cause feelings of empathy and emotional closeness. The exact mechanism of action of BK-EBDP is not fully understood.

Effects and Risks

The effects of BK-EBDP can vary depending on the dose, route of administration, and individual tolerance. Common effects include feelings of euphoria, increased energy, and increased sociability. Some users may also experience heightened sensory perception and increased empathy. However, there are also potential risks associated with the use of BK-EBDP. The drug can cause hypertension, tachycardia, and hyperthermia, which can be dangerous, especially at high doses. Long-term use of BK-EBDP may also lead to addiction, as well as negative effects on physical and mental health.

Legal Status

BK-EBDP is a controlled substance in many countries, including Sweden, where it is classified as a narcotic substance under the Act on Control of Narcotics. The drug is also listed as a Schedule I controlled substance in the United States, which means it is illegal to manufacture, distribute, or possess without a license.

Conclusion

BK-EBDP is a synthetic stimulant drug that acts as a dopamine and norepinephrine reuptake inhibitor and a serotonin releaser. The drug has gained popularity as a designer drug and is often sold online as a research chemical. While BK-EBDP can cause feelings of euphoria and increased sociability, there are also potential risks associated with its use, including hypertension, tachycardia, hyperthermia, addiction, and negative effects on physical and mental health. It is important to note that BK-EBDP is a controlled substance in many countries and its use can result in legal consequences.